BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11895790)

  • 1. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition.
    Dias S; Shmelkov SV; Lam G; Rafii S
    Blood; 2002 Apr; 99(7):2532-40. PubMed ID: 11895790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis.
    Baek JH; Jang JE; Kang CM; Chung HY; Kim ND; Kim KW
    Oncogene; 2000 Sep; 19(40):4621-31. PubMed ID: 11030151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.
    Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J
    J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
    Dias S; Hattori K; Zhu Z; Heissig B; Choy M; Lane W; Wu Y; Chadburn A; Hyjek E; Gill M; Hicklin DJ; Witte L; Moore MA; Rafii S
    J Clin Invest; 2000 Aug; 106(4):511-21. PubMed ID: 10953026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy.
    Dias S; Choy M; Alitalo K; Rafii S
    Blood; 2002 Mar; 99(6):2179-84. PubMed ID: 11877295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
    Spiekermann K; Faber F; Voswinckel R; Hiddemann W
    Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
    Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells.
    Dunk C; Ahmed A
    Am J Pathol; 2001 Jan; 158(1):265-73. PubMed ID: 11141500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
    Zeng H; Sanyal S; Mukhopadhyay D
    J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt.
    Wick A; Wick W; Waltenberger J; Weller M; Dichgans J; Schulz JB
    J Neurosci; 2002 Aug; 22(15):6401-7. PubMed ID: 12151519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
    Suzuma K; Naruse K; Suzuma I; Takahara N; Ueki K; Aiello LP; King GL
    J Biol Chem; 2000 Dec; 275(52):40725-31. PubMed ID: 11018037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.
    Colavitti R; Pani G; Bedogni B; Anzevino R; Borrello S; Waltenberger J; Galeotti T
    J Biol Chem; 2002 Feb; 277(5):3101-8. PubMed ID: 11719508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF.
    Wang D; Donner DB; Warren RS
    J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells.
    Murata M; Kador PF; Sato S
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.